Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects

Heart and Vessels

Volumn 26, Issue 4, 2011, Pages 428-434

  Nagashima, Hirotaka ^a,b   Endo, Masahiro ^a  

^a Osaki Hospital   (Japan)

^b Yanagibashi Hospital   (Japan)

Author keywords

Endothelial function; Pitavastatin; Postprandial response; Triglycerides

Indexed keywords

PITAVASTATIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MALE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; DIETARY FATS; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTRIGLYCERIDEMIA; JAPAN; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD; QUINOLINES; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; VASODILATION;

EID: 80051474919     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0071-7     Document Type: Article

References (25)

1. BG Nordestgaard M Benn P Schnohr A Tybjaerg-Hansen 2007 Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 299 308 17635890 10.1001/jama.298.3.299 1:CAS:528:DC%2BD2sXotVWmsrk%3D (Pubitemid 47080484)
2. S Bansal JE Buring N Rifai S Mora FM Sacks PM Ridker 2007 Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 309 316 17635891 10.1001/jama.298.3.309 1:CAS:528: DC%2BD2sXotValtb0%3D (Pubitemid 47080485)
3. S Teno Y Uto H Nagashima Y Endoh Y Iwamoto Y Omori T Takizawa 2000 Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes Diabetes Care 23 1401 1406 10977041 10.2337/diacare.23.9.1401 1:STN:280:DC%2BD3M%2Fls1SmtA%3D%3D
4. HW Wilmink MB Twickler JD Banga GM Dallinga-Thie H Eeltink DW Erkelens TJ Rabelink ES Stroes 2001 Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles Cardiovasc Res 50 577 582 11376633 10.1016/S0008-6363(01)00227-9 1:CAS:528:DC%2BD3MXjslelsr4%3D (Pubitemid 32480251)
5. RA Vogel MC Corretti GD Plotnick 1997 Effect of a single high-fat meal on endothelial function in healthy subjects Am J Cardiol 79 350 354 9036757 10.1016/S0002-9149(96)00760-6 1:STN:280:DyaK2s7nvFSisg%3D%3D (Pubitemid 27093313)
6. V Umpaichitra MA Banerji S Castells 2004 Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity J Pediatr Endocrinol Metab 17 853 864 15270403 10.1515/JPEM.2004.17. 6.853 (Pubitemid 38997089)
7. Y Nabeno Y Fukuchi Y Matsutani M Naito 2007 Influence of aging and menopause on postprandial lipoprotein responses in healthy adult women J Atheroscler Thromb 14 142 150 17587766 10.5551/jat.14.142 1:CAS:528: DC%2BD2sXot1Krs78%3D
8. A Ceriello C Taboga L Tonutti L Quagliaro L Piconi B Bais R Da Ros E Motz 2002 Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment Circulation 106 1211 1218 12208795 10.1161/01.CIR.0000027569.76671.A8 (Pubitemid 34988638)
9. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity 2002 New criteria for 'obesity disease' in Japan Circ J 66 987 992 10.1253/circj.66.987 (Pubitemid 35416333)
10. M Ai A Tanaka K Ogita M Sekinc F Numano F Numano GM Reaven 2001 Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes J Am Coll Cardiol 38 1628 1632 11704373 10.1016/S0735-1097(01)01611-4 1:CAS:528: DC%2BD3MXptVyhtbo%3D (Pubitemid 33065446)
11. M Okada H Matsui Y Ito A Fujiwara K Inano 1998 Low-density lipoprotein cholesterol can be chemically measured: a new superior method J Lab Clin Med 132 195 201 9735925 10.1016/S0022-2143(98)90168-8 1:CAS:528:DyaK1cXmt1eqs7w%3D (Pubitemid 28422255)
12. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome (2005) Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 94:794-809 (in Japanese)
13. F Karpe G Steiner K Uffelman T Olivecrona A Hamsten 1994 Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 106 83 97 8018110 10.1016/0021-9150(94)90085-X 1:STN:280:DyaK2c3ovVygsw%3D%3D (Pubitemid 24103802)
14. J Björkegren S Boquist A Samnegârd P Lundman P Tornvall CG Ericsson A Hamsten 2000 Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease Circulation 101 227 230 10645915 (Pubitemid 30054146)
15. FM Maggi S Raselli L Grigore L Redaelli S Fantappiè AL Catapano 2004 Lipoprotein remnants and endothelial dysfunction in the postprandial phase J Clin Endocrinol Metab 89 2946 2950 15181082 10.1210/jc.2003-031977 1:CAS:528:DC%2BD2cXmtlKjs7s%3D (Pubitemid 38766390)
16. RA Anderson ML Evans GR Ellis J Graham K Morris SK Jackson MJ Lewis A Rees MP Frenneaux 2001 The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes Atherosclerosis 154 475 483 11166782 10.1016/S0021-9150(00) 00499-8 1:CAS:528:DC%2BD3MXpt12ltA%3D%3D (Pubitemid 32146622)
17. A Ceriello E Motz 2004 Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 816 823 14976002 10.1161/01.ATV.0000122852.22604.78 1:CAS:528:DC%2BD2cXjsFSntLo%3D (Pubitemid 38620857)
18. GR Hajer GM Dallinga-Thie LC der Zee JK Olijhoek FL Visseren 2008 Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial Clin Endocrinol (Oxf) 69 870 877 10.1111/j.1365-2265.2008.03250.x 1:CAS:528:DC%2BD1MXmtlOisQ%3D%3D
19. Y Kitta JE Obata T Nakamura M Hirano Y Kodama D Fujioka Y Saito K Kawabata K Sano T Kobayashi T Yano K Nakamura K Kugiyama 2009 Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease J Am Coll Cardiol 53 323 330 19161880 10.1016/j.jacc.2008.08.074
20. KG Parhofer PH Barrett P Schwandt 2000 Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects J Clin Endocrinol Metab 85 4224 4230 11095458 10.1210/jc.85.11.4224 1:CAS:528:DC%2BD3cXotlWnu7c%3D (Pubitemid 32055377)
21. S Morikawa M Umetani S Nakagawa H Yamazaki H Suganami K Inoue M Kitahara T Hamakubo T Kodama Y Saito 2000 Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells J Atheroscler Thromb 7 138 144 11480454 1:CAS:528:DC%2BD3MXktlelsLk%3D
22. H Suzuki T Aoki T Tamaki F Sato M Kitahara Y Saito 1999 Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs Atherosclerosis 146 259 270 10532682 10.1016/S0021-9150(99)00146-X 1:CAS:528:DyaK1MXls12hurw%3D (Pubitemid 29418057)
23. U Landmesser F Bahlmann M Mueller S Spiekermann N Kirchhoff S Schulz C Manes D Fischer K de Groot D Fliser G Fauler W März H Drexler 2005 Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans Circulation 111 2356 2363 15867181 10.1161/01.CIR.0000164260.82417.3F 1:CAS:528:DC%2BD2MXjsl2itrg%3D (Pubitemid 40647072)
24. Rikitake Y, Liao JK (2005) Rho GTPases, statins, and nitric oxide. Circ Res 97:1232-1235 (review)
25. Liao JK (2002) Isoprenoids as mediators of the biological effects of statins. J Clin Invest 110:285-288 (review) (Pubitemid 34847957)